Mustang Bio shareholders authorize board to effect reverse stock split up to 20:1

MUSTANG BIO, INC.

Holders of ~62.2% voting power signed written consent approving reverse stock split.
Board authorized to set ratio between 5:1 and 20:1, with split to occur before Jan 31, 2024.
Consent signed by holders of 22,630,620 common shares and 250,000 Class A Preferred shares.
Board also approved the reverse stock split and amendment to certificate of incorporation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.